Cantseethewoodsforthetrees
05 Dec 2017
RNS-US appointment Nothing on the numbers, just US CEO appointed. Not before time I guess.
Cantseethewoodsforthetrees
22 Nov 2017
Re: NEW ARTICLE: Can this AIM-listed champio... I'll need to check, but I'm pretty sure this is the worst argued & most poorly written 'analysis' in the history of iii.Pathetic.
garyob
22 Nov 2017
Re: NEW ARTICLE: Surging Fevertree share... Won't be hanging onto this one for long , will take the 10% hit and be gone.
II Editor
22 Nov 2017
NEW ARTICLE: Can this AIM-listed champion retest record highs? "Fevertree Drinks (LSE:FEVR)With a corporate name like this, we wonder why this mob don't sponsor "I'm a Nonentity" which is currently polluting UK TV screens! It certainly would tend to add something to the vacant lot of people confusing fleeting ..."[link]
II Editor
21 Nov 2017
NEW ARTICLE: Trends and Targets for 22/11/2017 " FEVERTREE DRINKS (LSE:FEVR) With a corporate name like this, we wonder why this mob don't sponsor "I'm a Nonentity" which is currently polluting UK TV screens! It certainly would tend add something to the vacant lot of people confusing ..."[link]
Phronesis
15 Nov 2017
Re: Where to next "Currently waiting. I was in by 20k at one point and had a high average purchase price as I chased upwards from about £15-17 when I first got interested.Managed to about break even but enjoyed the ride." hmm, this sounds familiar to me. Sold out with a very modest profit of 10%. What's a good entry point? Any chartists around?
Chicken Lips
15 Nov 2017
Re: Where to next Well it is distinctly heading south on what has been pretty good news and a trajectory of positive sales. Meteoric rises are always vulnerable to equally sentimentally driven dips. I suppose the waiting game here is to see how far FEVR is going to fall. Still a great company and share in spite of all competition.Currently waiting. I was in by 20k at one point and had a high average purchase price as I chased upwards from about £15-17 when I first got interested.Managed to about break even but enjoyed the ride.
the greedies
13 Nov 2017
Where to next Technicals not great, looks as if may fall more.Still huge PE ratio which is always subject to big dips on any negative news.It is a great product and sales are going well but the market it's in has sleeping giants with no major barrier to entry. So far it's a disruptor in that industry but the big guns may either up their game or take it out.Interesting tim
skimp
09 Nov 2017
Re: Wow Bought more in the dip, it's a wait and see.
Cantseethewoodsforthetrees
08 Nov 2017
Today's Times fevertree drinks2017 Forecast revenue £158.3m Forecast pre-tax profit £54.5mThe Times8 November 2017How could we have doubted it? The recent fears over trading that had sent the Fevertree Drinks share price plunging by 25 per cent from its high of £25.35 a couple of months ago were well and truly dissipated yesterday by yet another forecast-busting update.The premium tonic and mixers group said that it expected its fullyear results to be “materially ahead of current market expectations” (the 11th upgrade in a row since it floated three years ago) and the shares duly regained their fizz, leaping by 292p, or 14.9 per cent, to £22.53, valuing the company at £2.3 billion. Not bad, given its issue price of 134p.The recent share weakness is probably symptomatic of the wider febrile nature of the markets. Nonetheless, analysts had highlighted the recent (belated) push by Coca-Cola Schweppes into the posh end of the tonic market as a threat to Fevertree. The Coke bottler claimed that the introduction of a premium range called Schweppes 1783 was the biggest British launch in its 234-year history.Tim Warrillow, co-founder and chief executive of Fevertree, was dismissive of Schweppes’ move, claiming that most of its rival’s marketing efforts were actually going into the relaunch of its mainstream brand rather than its new premium variant. He said that although mixers were now the fastest-growing part of the UK soft drinks market, Fevertree was behind that increase, accounting for 97 per cent of the value growth in retail over the past 12 months.Although Fevertree is growing rapidly overseas, selling in upwards of 70 countries, the driver of the latest upgrade was Britain, which is leading the posh gin charge. Fevertree now has a remarkable 35 per cent share of the off-trade.The company is not resting on its laurels and is continuing to use its resources (it had net cash on the balance sheet of £40.5 million at the half-year) to launch new products. It has just introduced a clementine-flavoured tonic with cinnamon for the festive season, while its new range of mixers aimed at the dark spirits market is showing promise, albeit that it is still early days.
Cantseethewoodsforthetrees
08 Nov 2017
Re: Wow Well, almost.
garyob
07 Nov 2017
Re: Wow and it did....
Cantseethewoodsforthetrees
07 Nov 2017
Re: Wow Answer my own post....Yes it can! 
)
garyob
07 Nov 2017
Re: NEW ARTICLE: Surging Fevertree shares ba... Well that boosts the confidence for a new holder like myself after the recent falls , it's always questionable to buy near the top. I should have bought at 1200 but told myself they couldn't keep going up , so didn't....and bought at 2195 instead!!
II Editor
07 Nov 2017
NEW ARTICLE: Surging Fevertree shares back on form "Posh mixers firm LSE:FEVR:Fevertree Drinks reminded us why it is AIM Company of the Year today as it upgraded profits guidance for the fifth time in just 12 months. The now customary revision to forecasts boosted the share price by 12% to 2,266p, ..."[link]
